Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

The merozoite surface protein-1 (MSP1) is the most studied malaria blood-stage vaccine candidate. Lymphokines such as interferon gamma (IFN-gamma) and interleukin 4 (IL-4) may mediate blood-stage specific protection. Here we identify Plasmodiumfalciparum MSP1 T-cell epitopes capable of rapid induction of IFN-gamma and/or IL-4 from peripheral blood mononuclear cells of East and West African donors. Both allelic forms of these novel MSP1 T-cell epitopes were stimulatory. An unusually high numbers of Gambian responders (> 80%) to these epitopes were observed, suggesting that MSPI reactivity may have been underestimated previously in this population. Surprisingly, IFN-gamma responses to allelic T-cell epitopes failed to correlate with differential antigenic exposure in The Gambia compared to Kenya. These results suggest an unexpected level of immunoregulation of IFN-gamma response with variable allelic T-cell reactivity independent of the level of antigenic exposure. Further analysis of the mechanisms determining this response pattern may be required if vaccines are to overcome this allelic reactivity bias in malaria-exposed populations.

Type

Journal article

Journal

Am J Trop Med Hyg

Publication Date

03/2001

Volume

64

Pages

194 - 203

Keywords

Adolescent, Adult, Alleles, Amino Acid Sequence, Animals, Case-Control Studies, DNA Primers, Epitopes, T-Lymphocyte, Female, Gambia, Humans, Interferon-gamma, Interleukin-4, Kenya, Malaria, Falciparum, Male, Merozoite Surface Protein 1, Middle Aged, Molecular Sequence Data, Plasmodium falciparum, Polymerase Chain Reaction, Prevalence, T-Lymphocytes